FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

40508611000001104: Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2189921000001111 Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2189941000001118 Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Has VMP Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sodium glycerophosphate true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Has specific active ingredient Sodium glycerophosphate pentahydrate true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium glycerophosphate 4.32g/20ml concentrate for solution for infusion ampoules (Fresenius Kabi Ltd) 1 ampoule Is a True Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules 1 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start